Consensus Roche Holding AG Deutsche Boerse AG

Equities

RHO

CH0012032113

Market Closed - Deutsche Boerse AG Other stock markets 11:41:39 2019-06-28 EDT			5-day change	1st Jan Change
247.6 ^EUR	+0.81%		-.--%	-.--%

06-25	Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval	MT
06-25	Roche: approval of Ocrevus SC in Europe	CF

Evolution of the average Target Price on Roche Holding AG

Price target over the last 5 years

History of analyst recommendation changes

61c1813c99ed7fc16a7b.E2gk6mRuAHrRyKTG3iw0Co2o4C1P65bK2tUt_R8Dlhw.VDxIuwMMURm_hJKAum9RXeT9jx14ucmPmZxll2xB-Vp9W0DaUxhuKqORkA~cb439873cf14f05b39b2de66c9737947

Analyst Recommendations on Roche Holding AG

ROCHE HOLDINGS AG : Barclays reiterates its Neutral rating	06-24	ZD
Nykredit Bank Initiates Coverage on Roche With Buy Recommendation	06-21	MT
Nykredit Bank Starts Roche Coverage at Buy	06-21	MT
ROCHE HOLDINGS AG : UBS reiterates its Neutral rating	06-20	ZD
ROCHE HOLDINGS AG : Goldman Sachs gives a Sell rating	06-17	ZD
ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral	06-17	ZD
ROCHE HOLDINGS AG : Gets a Neutral rating from Barclays	06-17	ZD
ROCHE HOLDINGS AG : JP Morgan gives a Sell rating	06-17	ZD
AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Buy Recommendation	06-06	MT
ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating	06-03	ZD
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	06-03	ZD
ROCHE HOLDINGS AG : Gets a Neutral rating from UBS	05-31	ZD
ROCHE HOLDINGS AG : Goldman Sachs remains a Sell rating	05-30	ZD
ROCHE HOLDINGS AG : Gets a Neutral rating from Deutsche Bank	05-24	ZD
ROCHE HOLDINGS AG : UBS sticks Neutral	05-17	ZD
Deutsche Bank Upgrades Roche to Hold from Sell	05-17	MT
ROCHE : Deutsche Bank no longer sells	05-17	CF
ROCHE HOLDINGS AG : Deutsche Bank Upgrades to Neutral	05-17	ZD
ROCHE HOLDINGS AG : Receives a Sell rating from JP Morgan	05-16	ZD
ROCHE HOLDINGS AG : Jefferies remains Neutral	05-16	ZD
ROCHE HOLDINGS AG : UBS remains Neutral	05-14	ZD
ROCHE HOLDINGS AG : UBS reiterates its Neutral rating	05-06	ZD
Criticism of Bayer CEO - "A successful start looks different"	04-26	RE
ROCHE : Barclays lowers target price	04-25	CF
ROCHE HOLDINGS AG : UBS remains Neutral	04-25	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

253.4 CHF

Average target price

278.1 CHF

Spread / Average Target

+9.73%

High Price Target

428 CHF

Spread / Highest target

+68.90%

Low Price Target

210 CHF

Spread / Lowest Target

-17.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Roche Holding AG

BARCLAYS	Emily Field
Nykredit Bank
UBS	Matthew Weston
GOLDMAN SACHS	James Quigley
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JPMORGAN	Richard Vosser
AlphaValue
JEFFERIES	Peter Welford
DZ BANK	Elmar Kraus
BERNSTEIN RESEARCH
BERENBERG	Luisa Hector
Redburn
Stifel Nicolaus
BNP Paribas
MORGAN STANLEY	Mark Purcell
Societe Generale
CREDIT SUISSE	Dominic Lunn
Octagon Capital
HSBC
Kepler Capital Markets
Vista Partners
Berenberg Bank
ODDO BHF
International Strategy & Investment Group
Deutsche Bank Securities
BANK OF AMERICA (BOFA)	Sachin Jain
Bryan, Garnier & Co.
DEUTSCHE BANK	Emmanuel Papadakis
Wolfe Research
KEPLER CHEUVREUX
Jefferies & Co.
Morgan Lewins & Co.
Independent Research
Dawson James
Exane BNP
Bernstein
Dundee
Banco Santander
CITIGROUP	Andrew Baum
Liberum Capital

Ratings for Roche Holding AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar